|
| |
BURT M. SHARP, M.D.
- Van Vleet Professor and Chair
- Department of Pharmacology
- Co-Director, Center for Neurobiology of Brain Disease
- The University of Tennessee Health Science Center
Address
- The University of Tennessee Health Science Center
- 874 Union Avenue
- Memphis, TN 38163
- Tel: (901) 448-6000; Fax: (901) 448-7300;
- Lab: 115 Crowe Research Building
Education
- M.D. Institution: University of Cincinnati
Research Interests
This reseach program has dual foci involving (1) the basic neuro-chemistry and molecular neurobiology of nicotine and (2) cellular and biochemical approaches to understand the action of opioid peptides on the immune system.
The nicotine research uses in vivo microdialysis coupled with measurements of biogenic amines and excitatory amino acids to understand both the neurochemical basis for addiction to nicotine and the beneficial therapeutic effects of nicotinic agonists on hypothalamic and hippocampal function. In many of these studies, nicotine is delivered acutely through intra-jugular catheters and cannulae that are chronically implanted in specific CNS sites. Animals also learn to self-administer nicotine through operant conditioning that mimics human smoking. In vivo microdialysis in these self-administering animals permits analysis of changes in brain neurochemistry and direct correlation of these with drug-dependent behavior. Using RT-PCR, analyses are made of specific gene expression in micropunched areas of brain. Similarly, in situ hybridization analyses are used to characterize the effects of nicotine self-administration on short and longterm changes in CNS gene expression.
Dr. Sharp's research on opioid immunobiology seeks to understand the cellular and molecular basis for the modulatory effects of opiates and opioid peptides on lymphocytes, specifically T-cells. Using fluorescence flow cytometry and RT-PCR, his lab is characterizing the expression of delta opioid receptors on specific subsets of T lymphocytes. Biochemical and immunological approaches (e.g., immunoprecipitation, Western immunoblotting, receptor binding, etc.) are used to elucidate the signal transduction pathways that mediate the anti-proliferative actions of delta opioid receptors on T-cells. Their current focus is on the role of mitogen-activated protein kinases (MAPKs) in opioid signaling, as this pertains to the effects of opioids on MAPK-dependent interleukin-2 production.
Links
- Pharmacology - Burt Sharp
Recent Publications
- Wang F, Chen H, Sharp BM.
Neuroadaptive changes in the mesocortical glutamatergic system during chronic
nicotine self-administration and after extinction in rats.
J Neurochem. 2008 Jul;106(2):943-56. Epub 2008 May 3.
PMID: 18466321
- Yu G, Chen H, Zhao W, Matta SG, Sharp BM.
Nicotine self-administration differentially regulates hypothalamic
corticotropin-releasing factor and arginine vasopressin mRNAs and facilitates
stress-induced neuronal activation.
J Neurosci. 2008 Mar 12;28(11):2773-82.
PMID: 18337407
- Shahabi NA, McAllen K, Sharp BM.
Stromal cell-derived factor 1-alpha (SDF)-induced human T cell chemotaxis
becomes phosphoinositide 3-kinase (PI3K)-independent: role of PKC-theta.
J Leukoc Biol. 2008 Mar;83(3):663-71. Epub 2007 Nov 30.
PMID: 18055570
- Chen H, Fu Y, Sharp BM.
Chronic nicotine self-administration augments hypothalamic-pituitary-adrenal
responses to mild acute stress.
Neuropsychopharmacology. 2008 Mar;33(4):721-30. Epub 2007 Jun 6.
PMID: 17551542
- Zhao R, Chen H, Sharp BM.
Nicotine-induced norepinephrine release in hypothalamic paraventricular nucleus
and amygdala is mediated by N-methyl-D-aspartate receptors and nitric oxide in
the nucleus tractus solitarius.
J Pharmacol Exp Ther. 2007 Feb;320(2):837-44. Epub 2006 Nov 8.
PMID: 17093131
- Chen H, Matta SG, Sharp BM.
Acquisition of nicotine self-administration in adolescent rats given prolonged
access to the drug.
Neuropsychopharmacology. 2007 Mar;32(3):700-9. Epub 2006 Jun 14.
PMID: 16794562
view complete list of references (pubmed link)
|
|
|